{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T12:39:08Z","timestamp":1793104748021,"version":"4.5.0"},"reference-count":74,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T00:00:00Z","timestamp":1787529600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","phiro.science","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Physics and Imaging in Radiation Oncology"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.phro.2026.101071","type":"journal-article","created":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T23:46:26Z","timestamp":1787701586000},"page":"101071","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Clinical implementation of intensity modulated proton therapy in breath-hold for mediastinal lymphoma patients using surface monitoring and nasal high-flow therapy"],"prefix":"10.1016","volume":"41","author":[{"given":"Gloria","family":"Vilches-Freixas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kim","family":"van der Klugt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Canters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther","family":"Kneepkens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fleur","family":"Vereijken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maud","family":"Cobben","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maud","family":"van den Bosch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Indra","family":"Lubken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"van Engelen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cissy","family":"Stultiens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marije","family":"Velders","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgio","family":"Cartechini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirko","family":"Unipan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maaike","family":"Berb\u00e9e","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bastiaan","family":"Ta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.phro.2026.101071_bb0005","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1200\/JCO.2013.51.7524","article-title":"[18F] fluorodeoxyglucose positron emission tomography predicts survival after chemoimmunotherapy for primary mediastinal large B-cell lymphoma: results of the international Extranodal lymphoma study group IELSG-26 study","volume":"32","author":"Martelli","year":"2014","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.phro.2026.101071_bb0010","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.ijrobp.2016.09.031","article-title":"Positron emission tomography\/computed tomography assessment after immunochemotherapy and irradiation using the Lugano classification criteria in the IELSG-26 study of primary mediastinal B-cell lymphoma","volume":"97","author":"Ceriani","year":"2017","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.phro.2026.101071_bb0015","doi-asserted-by":"crossref","first-page":"4071","DOI":"10.1200\/JCO-24-01373","article-title":"Omission of radiotherapy in primary mediastinal B-cell lymphoma: IELSG37 trial results","volume":"42","author":"Martelli","year":"2024","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.phro.2026.101071_bb0020","doi-asserted-by":"crossref","first-page":"2803","DOI":"10.1182\/blood.2019004296","article-title":"Outcome of primary mediastinal large B-cell lymphoma using R-CHOP: impact of a PET-adapted approach","volume":"136","author":"Hayden","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.phro.2026.101071_bb0025","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1200\/JCO.2016.68.6394","article-title":"Early positron emission tomography response\u2013adapted treatment in stage I and II Hodgkin lymphoma: final results of the randomized EORTC\/LYSA\/FIL H10 trial","volume":"35","author":"Andr\u00e9","year":"2017","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.phro.2026.101071_bb0030","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1016\/S0140-6736(14)61469-0","article-title":"Omission of dacarbazine or bleomycin, or both, from the ABVD regimen in treatment of early-stage favourable Hodgkin\u2019s lymphoma (GHSG HD13): an open-label, randomised, non-inferiority trial","volume":"385","author":"Behringer","year":"2015","journal-title":"The Lancet"},{"key":"10.1016\/j.phro.2026.101071_bb0035","doi-asserted-by":"crossref","first-page":"4199","DOI":"10.1200\/JCO.2010.29.8018","article-title":"Intensified chemotherapy and dose-reduced involved-field radiotherapy in patients with early Unfavorable Hodgkin\u2019s lymphoma: final analysis of the German Hodgkin study group HD11 trial","volume":"28","author":"Eich","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.phro.2026.101071_bb0040","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1056\/NEJMoa1000067","article-title":"Reduced treatment intensity in patients with early-stage Hodgkin\u2019s lymphoma","volume":"363","author":"Engert","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.phro.2026.101071_bb0045","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1056\/NEJMoa1408648","article-title":"Results of a trial of PET-directed therapy for early-stage Hodgkin\u2019s lymphoma","volume":"372","author":"Radford","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.phro.2026.101071_bb0050","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1200\/JCO.2009.26.2493","article-title":"Standard international prognostic index remains a valid predictor of outcome for patients with aggressive CD20 + B-cell lymphoma in the rituximab era","volume":"28","author":"Ziepert","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.phro.2026.101071_bb0055","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.1056\/NEJMoa1510093","article-title":"Adapted treatment guided by interim PET-CT scan in advanced Hodgkin\u2019s lymphoma","volume":"374","author":"Johnson","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.phro.2026.101071_bb0060","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1200\/JCO.2005.05.022","article-title":"Salvage radiotherapy in patients with relapsed and refractory Hodgkin\u2019s lymphoma: a retrospective analysis from the German Hodgkin lymphoma study group","volume":"23","author":"Josting","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.phro.2026.101071_bb0065","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.ijrobp.2014.09.041","article-title":"Rates and durability of response to salvage radiation therapy among patients with refractory or relapsed aggressive non-Hodgkin lymphoma","volume":"91","author":"Tseng","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.phro.2026.101071_bb0070","doi-asserted-by":"crossref","first-page":"6487","DOI":"10.1158\/1078-0432.CCR-06-1420","article-title":"Long-term events in adult patients with clinical stage IA-IIA nonbulky Hodgkin\u2019s lymphoma treated with four cycles of doxorubicin, bleomycin, vinblastine, and dacarbazine and adjuvant radiotherapy: a single-institution 15-year follow-up","volume":"12","author":"Brusamolino","year":"2006","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.phro.2026.101071_bb0075","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/j.ijrobp.2017.05.004","article-title":"Evidence-based review on the use of proton therapy in lymphoma from the particle therapy cooperative group (PTCOG) lymphoma subcommittee","volume":"99","author":"Tseng","year":"2017","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.phro.2026.101071_bb0080","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1093\/jnci\/djaa194","article-title":"Long-term cause-specific mortality in Hodgkin lymphoma patients","volume":"113","author":"de Vries","year":"2021","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.phro.2026.101071_bb0085","doi-asserted-by":"crossref","first-page":"3431","DOI":"10.1200\/JCO.2003.07.131","article-title":"Long-term cause-specific mortality of patients treated for Hodgkin\u2019s disease","volume":"21","author":"Aleman","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.phro.2026.101071_bb0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.esmoop.2024.102248","article-title":"Treatment-specific risk of subsequent malignant neoplasms in five-year survivors of diffuse large B-cell lymphoma","volume":"9","author":"Geurts","year":"2024","journal-title":"ESMO Open"},{"key":"10.1016\/j.phro.2026.101071_bb0095","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1200\/JCO.2015.63.4444","article-title":"Radiation dose-response relationship for risk of coronary heart disease in survivors of Hodgkin lymphoma","volume":"34","author":"van Nimwegen","year":"2016","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.phro.2026.101071_bb0100","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/djv008","article-title":"Risk for valvular heart disease after treatment for Hodgkin lymphoma","volume":"107","author":"Cutter","year":"2015","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.phro.2026.101071_bb0105","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1182\/blood-2016-09-740332","article-title":"Risk of heart failure in survivors of Hodgkin lymphoma: effects of cardiac exposure to radiation and anthracyclines","volume":"129","author":"van Nimwegen","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.phro.2026.101071_bb0110","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1056\/NEJMoa1505949","article-title":"Second Cancer risk up to 40 years after treatment for Hodgkin\u2019s lymphoma","volume":"373","author":"Schaapveld","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.phro.2026.101071_bb0115","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.clon.2015.03.005","article-title":"Involved node, site, field and residual volume radiotherapy for lymphoma: a comparison of organ at risk dosimetry and second malignancy risks","volume":"27","author":"Murray","year":"2015","journal-title":"Clin Oncol"},{"key":"10.1016\/j.phro.2026.101071_bb0120","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1093\/jnci\/djac125","article-title":"Radiotherapy-related dose and irradiated volume effects on breast Cancer risk among Hodgkin lymphoma survivors","volume":"114","author":"Roberti","year":"2022","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.phro.2026.101071_bb0125","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.radonc.2013.06.041","article-title":"Long-term risk of secondary skin cancers after radiation therapy for Hodgkin\u2019s lymphoma","volume":"109","author":"Dani\u00ebls","year":"2013","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.phro.2026.101071_bb0130","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1093\/jnci\/95.13.971","article-title":"Roles of radiation dose, chemotherapy, and hormonal factors in breast cancer following Hodgkin\u2019s disease","volume":"95","author":"van Leeuwen","year":"2003","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.phro.2026.101071_bb0135","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.ijrobp.2015.01.013","article-title":"Minimizing late effects for patients with mediastinal Hodgkin lymphoma: deep inspiration breath-hold, IMRT, or Both?","volume":"92","author":"Aznar","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.phro.2026.101071_bb0140","doi-asserted-by":"crossref","DOI":"10.1259\/bjro.20200067","article-title":"Deep inspiration breath hold versus free breathing technique in mediastinal radiotherapy for lymphoma","volume":"3","author":"Houlihan","year":"2021","journal-title":"BJR|Open"},{"key":"10.1016\/j.phro.2026.101071_bb0145","doi-asserted-by":"crossref","first-page":"60","DOI":"10.3109\/0284186X.2014.932435","article-title":"Prospective phase II trial of image-guided radiotherapy in Hodgkin lymphoma: benefit of deep inspiration breath-hold","volume":"54","author":"Petersen","year":"2015","journal-title":"Acta Oncol"},{"key":"10.1016\/j.phro.2026.101071_bb0150","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.radonc.2018.08.017","article-title":"Comparison of butterfly volumetric modulated arc therapy to full arc with or without deep inspiration breath hold for the treatment of mediastinal lymphoma","volume":"129","author":"Starke","year":"2018","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.phro.2026.101071_bb0155","doi-asserted-by":"crossref","DOI":"10.3390\/cancers17121985","article-title":"Application of the deep inspiration breath-hold technique in proton therapy for mediastinal lymphomas: initial experience","volume":"17","author":"Garbacz","year":"2025","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.phro.2026.101071_bb0160","doi-asserted-by":"crossref","first-page":"62","DOI":"10.2340\/1651-226X.2024.23964","article-title":"Pencil beam scanning proton therapy for mediastinal lymphomas in deep inspiration breath-hold: a retrospective assessment of plan robustness","volume":"63","author":"H\u00f6rberger","year":"2024","journal-title":"Acta Oncol"},{"key":"10.1016\/j.phro.2026.101071_bb0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2025.110931","article-title":"Proton beam therapy for mediastinal Hodgkin lymphoma: a prospective study of clinical efficacy and safety","volume":"208","author":"D\u011bde\u010dkov\u00e1","year":"2025","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.phro.2026.101071_bb0170","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.tipsro.2019.11.006","article-title":"Pencil beam scanning proton therapy of Hodgkin\u2019s lymphoma in deep inspiration breath-hold: a case series report","volume":"13","author":"Andersson","year":"2020","journal-title":"Tech Innov Patient Support Radiat Oncol"},{"key":"10.1016\/j.phro.2026.101071_bb0175","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.radonc.2022.02.015","article-title":"Technical challenges in the treatment of mediastinal lymphomas by proton pencil beam scanning and deep inspiration breath-hold","volume":"169","author":"Righetto","year":"2022","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.phro.2026.101071_bb0180","doi-asserted-by":"crossref","DOI":"10.1259\/bjr.20210618","article-title":"The role of motion management and position verification in lymphoma radiotherapy","volume":"94","author":"Aznar","year":"2021","journal-title":"Br J Radiol"},{"key":"10.1016\/j.phro.2026.101071_bb0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2023.109734","article-title":"ESTRO-ACROP guideline: recommendations on implementation of breath-hold techniques in radiotherapy","volume":"185","author":"Aznar","year":"2023","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.phro.2026.101071_bb0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2023.109594","article-title":"Radiotherapy for mediastinal lymphoma in breath hold using surface monitoring and nasal high flow oxygen: clinical experiences and breath hold stability","volume":"183","author":"Canters","year":"2023","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.phro.2026.101071_bb0195","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1016\/j.ijrobp.2011.05.015","article-title":"Dosimetric benefits of intensity-modulated radiotherapy combined with the deep-inspiration breath-hold technique in patients with mediastinal Hodgkin\u2019s lymphoma","volume":"82","author":"Paumier","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.phro.2026.101071_bb0200","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.prro.2019.05.009","article-title":"Comparison of techniques for involved-site radiation therapy in patients with lower mediastinal lymphoma","volume":"9","author":"Everett","year":"2019","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.phro.2026.101071_bb0205","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.prro.2013.07.015","article-title":"Active breathing control for patients receiving mediastinal radiation therapy for lymphoma: impact on normal tissue dose","volume":"4","author":"Charpentier","year":"2014","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.phro.2026.101071_bb0210","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1080\/0284186X.2020.1856408","article-title":"Visually guided inspiration breath-hold facilitated with nasal high flow therapy in locally advanced lung cancer","volume":"60","author":"Peeters","year":"2021","journal-title":"Acta Oncol"},{"key":"10.1016\/j.phro.2026.101071_bb0215","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.radonc.2017.07.033","article-title":"Life years lost attributable to late effects after radiotherapy for early stage Hodgkin lymphoma: the impact of proton therapy and\/or deep inspiration breath hold","volume":"125","author":"Rechner","year":"2017","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.phro.2026.101071_bb0220","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1186\/s13014-018-1066-2","article-title":"Proton versus photon deep inspiration breath hold technique in patients with hodgkin lymphoma and mediastinal radiation","volume":"13","author":"Baues","year":"2018","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.phro.2026.101071_bb0225","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.prro.2019.01.006","article-title":"Clinical intensity modulated proton therapy for Hodgkin lymphoma: which patients benefit the Most?","volume":"9","author":"Ntentas","year":"2019","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.phro.2026.101071_bb0230","doi-asserted-by":"crossref","first-page":"1","DOI":"10.14338\/IJPT-20-00010.1","article-title":"Reducing heart dose with protons and cardiac substructure sparing for mediastinal lymphoma treatment","volume":"7","author":"Taparra","year":"2020","journal-title":"Int J Part Ther"},{"key":"10.1016\/j.phro.2026.101071_bb0235","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1186\/s13014-019-1432-8","article-title":"Comparative photon and proton dosimetry for patients with mediastinal lymphoma in the era of Monte Carlo treatment planning and variable relative biological effectiveness","volume":"14","author":"Tseng","year":"2019","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.phro.2026.101071_bb0240","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1016\/j.adro.2020.08.004","article-title":"Effect of deep inspiration breath hold on Normal tissue sparing with intensity modulated radiation therapy versus proton therapy for mediastinal lymphoma","volume":"5","author":"Moreno","year":"2020","journal-title":"Adv Radiat Oncol"},{"key":"10.1016\/j.phro.2026.101071_bb0245","article-title":"Improved organs-of-interest dose reduction potential with intensity modulated proton therapy and breath-hold in mediastinal lymphoma","volume":"39","author":"Ta","year":"2026","journal-title":"Phys Imaging Radiat Oncol"},{"key":"10.1016\/j.phro.2026.101071_bb0250","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.radonc.2022.10.003","article-title":"Systematic review for deep inspiration breath hold in proton therapy for mediastinal lymphoma: a PTCOG lymphoma subcommittee report and recommendations","volume":"177","author":"Patel","year":"2022","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.phro.2026.101071_bb0255","article-title":"Dosimetric evaluation and reproducibility of breath-hold plans in intensity modulated proton therapy: an initial clinical experience","volume":"9","author":"Sabouri","year":"2024","journal-title":"Adv Radiat Oncol"},{"key":"10.1016\/j.phro.2026.101071_bb0260","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.clon.2021.12.007","article-title":"Model-based selection for proton therapy in breast Cancer: development of the National Indication Protocol for proton therapy and first clinical experiences","volume":"34","author":"Boersma","year":"2022","journal-title":"Clin Oncol"},{"key":"10.1016\/j.phro.2026.101071_bb0265","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2025.110998","article-title":"Selection of patients for proton therapy to reduce risk of second primary lung and breast cancer","volume":"210","author":"Boersma","year":"2025","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.phro.2026.101071_bb0270","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.ijrobp.2014.01.006","article-title":"Modern radiation therapy for nodal non-Hodgkin lymphoma\u2014target definition and dose guidelines from the international lymphoma radiation oncology group","volume":"89","author":"Illidge","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.phro.2026.101071_bb0275","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1182\/blood-2018-03-837633","article-title":"Proton therapy for adults with mediastinal lymphomas: the international lymphoma radiation oncology group guidelines","volume":"132","author":"Dabaja","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.phro.2026.101071_bb0280","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.clon.2012.07.011","article-title":"Recommendations for the use of radiotherapy in nodal lymphoma","volume":"25","author":"Hoskin","year":"2013","journal-title":"Clin Oncol"},{"key":"10.1016\/j.phro.2026.101071_bb0285","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.radonc.2019.08.005","article-title":"Practical robustness evaluation in radiotherapy \u2013 a photon and proton-proof alternative to PTV-based plan evaluation","volume":"141","author":"Korevaar","year":"2019","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.phro.2026.101071_bb0290","doi-asserted-by":"crossref","DOI":"10.1259\/bjr.20190598","article-title":"Beam commissioning of the first compact proton therapy system with spot scanning and dynamic field collimation","volume":"93","author":"Vilches-Freixas","year":"2020","journal-title":"Br J Radiol"},{"key":"10.1016\/j.phro.2026.101071_bb0295","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1053\/j.semradonc.2003.10.003","article-title":"Errors and margins in radiotherapy","volume":"14","author":"Van Herk","year":"2004","journal-title":"Semin Radiat Oncol"},{"key":"10.1016\/j.phro.2026.101071_bb0300","series-title":"NCS report 37: Code of practice and recommendations for stereotactic body radiotherapy. Delft","author":"Cuijpers","year":"2024"},{"key":"10.1016\/j.phro.2026.101071_bb0305","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2024.110409","article-title":"Robustness of intensity modulated proton treatment of esophageal cancer for anatomical changes and breathing motion","volume":"198","author":"Canters","year":"2024","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.phro.2026.101071_bb0310","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.ijrobp.2021.09.015","article-title":"Diaphragm-based position verification to improve daily target dose coverage in proton and photon radiation therapy treatment of distal Esophageal Cancer","volume":"112","author":"Visser","year":"2022","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.phro.2026.101071_bb0315","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1080\/0284186X.2022.2091949","article-title":"Bone versus soft-tissue setup in proton therapy for patients with oesophageal cancer","volume":"61","author":"Shamshad","year":"2022","journal-title":"Acta Oncol"},{"key":"10.1016\/j.phro.2026.101071_bb0320","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1186\/s13014-024-02564-w","article-title":"Bone matching versus tumor matching in image-guided carbon ion radiotherapy for locally advanced non-small cell lung cancer","volume":"19","author":"Mi","year":"2024","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.phro.2026.101071_bb0325","doi-asserted-by":"crossref","first-page":"195006","DOI":"10.1088\/1361-6560\/ac9109","article-title":"Accuracy and potential improvements of surface-guided breast cancer radiotherapy in deep inspiration breath-hold with daily image-guidance","volume":"67","author":"Nankali","year":"2022","journal-title":"Phys Med Biol"},{"key":"10.1016\/j.phro.2026.101071_bb0330","doi-asserted-by":"crossref","first-page":"193","DOI":"10.3109\/0284186X.2015.1045625","article-title":"Setup error and motion during deep inspiration breath-hold breast radiotherapy measured with continuous portal imaging","volume":"55","author":"Lutz","year":"2016","journal-title":"Acta Oncol"},{"key":"10.1016\/j.phro.2026.101071_bb0335","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.radonc.2013.04.021","article-title":"The UK HeartSpare study: randomised evaluation of voluntary deep-inspiratory breath-hold in women undergoing breast radiotherapy","volume":"108","author":"Bartlett","year":"2013","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.phro.2026.101071_bb0340","doi-asserted-by":"crossref","unstructured":"Wikstr\u00f6m K, Andersson KM, Helal S, Enmark M, Edvardsson A, Molin D, et al. Evaluation of the use of external abdominal information in deep inspiration breath-hold for mediastinal lymphoma patients. Available at SSRN: DOI:https:\/\/doi.org\/10.2139\/ssrn.6862441.","DOI":"10.2139\/ssrn.6862441"},{"key":"10.1016\/j.phro.2026.101071_bb0345","doi-asserted-by":"crossref","first-page":"125021","DOI":"10.1088\/1361-6560\/ae7bab","article-title":"A posteriori and predictive interplay evaluation methodology for lung and esophageal cancer patients treated in free breathing with IMPT","volume":"71","author":"Cartechini","year":"2026","journal-title":"Phys Med Biol"},{"key":"10.1016\/j.phro.2026.101071_bb0350","article-title":"Dosimetric evaluation of target motion effects in spot-scanning proton therapy: a phantom study","volume":"11","author":"Belikhin","year":"2024","journal-title":"Int J Part Ther"},{"key":"10.1016\/j.phro.2026.101071_bb0355","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.mayocp.2013.11.007","article-title":"Postoperative acute respiratory distress syndrome in patients with previous exposure to bleomycin","volume":"89","author":"Aakre","year":"2014","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.phro.2026.101071_bb0360","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.radonc.2018.12.026","article-title":"Mechanically-assisted non-invasive ventilation: a step forward to modulate and to improve the reproducibility of breathing-related motion in radiation therapy","volume":"133","author":"Van Ooteghem","year":"2019","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.phro.2026.101071_bb0365","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1186\/s13014-022-02068-5","article-title":"Quantifying the reduction of respiratory motion by mechanical ventilation with MRI for radiotherapy","volume":"17","author":"van Kesteren","year":"2022","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.phro.2026.101071_bb0370","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJMoa1209825","article-title":"Risk of ischemic heart disease in women after radiotherapy for breast Cancer","volume":"368","author":"Darby","year":"2013","journal-title":"N Engl J Med"}],"container-title":["Physics and Imaging in Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405631626001715?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405631626001715?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T12:28:35Z","timestamp":1793104115000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405631626001715"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":74,"alternative-id":["S2405631626001715"],"URL":"https:\/\/doi.org\/10.1016\/j.phro.2026.101071","relation":{},"ISSN":["2405-6316"],"issn-type":[{"value":"2405-6316","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical implementation of intensity modulated proton therapy in breath-hold for mediastinal lymphoma patients using surface monitoring and nasal high-flow therapy","name":"articletitle","label":"Article Title"},{"value":"Physics and Imaging in Radiation Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phro.2026.101071","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V. on behalf of European Society of Radiotherapy & Oncology.","name":"copyright","label":"Copyright"}],"article-number":"101071"}}